Skip to Highlights
Highlights

Pursuant to a congressional request, GAO reviewed the Patent and Trademark Office's (PTO) backlog of unprocessed biotechnology patent applications, focusing on: (1) the extent of the backlog; (2) the impact of PTO actions to accelerate biotechnology patent decisions; and (3) the impact of continuations on reported patent dependency time in 1989.

Full Report